A phase 1, first in human, multicenter, open-label, study of GQ1001, a HER2 targeted antibody-drug conjugate administered intravenously in adult patients with HER2 - positive advanced solid tumors [GQCT001/GQ1001X2101]

Project: Research

Project Details

StatusActive
Effective start/end date1/12/2031/12/24

Keywords

  • Medical oncology
  • Solid tumours
  • Clinical trial